Cargando…
Implications of the PEGASUS-TIMI 54 trial for US clinical practice
OBJECTIVES: This study aims to determine the proportion of real-world patients with myocardial infarction (MI) who would have been eligible for the PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin...
Autores principales: | Bradley, Steven M, Hess, Gregory P, Stewart, Patrick, Armstrong, Ehrin J, Farmer, Steven A, Wasfy, Jason H, Valle, Javier Alfonso, Sandhu, Amneet, Maddox, Thomas M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Heart
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471865/ https://www.ncbi.nlm.nih.gov/pubmed/28674626 http://dx.doi.org/10.1136/openhrt-2016-000580 |
Ejemplares similares
-
Orbital atherectomy of calcified coronary ostial lesions
por: Chambers, Jeffrey W., et al.
Publicado: (2022) -
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54
por: Bonaca, Marc P., et al.
Publicado: (2018) -
Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial
por: Bergmark, Brian A., et al.
Publicado: (2021) -
Lipoprotein particles and coronary artery calcium in middle-aged US-White and Japanese men
por: Mahajan, Hemant, et al.
Publicado: (2019) -
Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre
por: Patel, Alok Sunil, et al.
Publicado: (2015)